⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20511736 | 0.88 | — | — | |
| SCHEMBL2460127 | 0.88 | — | — | |
| SCHEMBL17748837 | 0.86 | — | — | |
| SCHEMBL11229927 | 0.84 | TSHR (0.38) | — | |
| SCHEMBL17868358 | 0.84 | TSHR (0.42) | — | |
| SCHEMBL17868359 | 0.84 | TSHR (0.42) | — | |
| SCHEMBL790274 | 0.80 | — | — | |
| SCHEMBL790275 | 0.80 | — | — | |
| SCHEMBL31132251 | 0.80 | FAAH (0.52) | — | |
| SCHEMBL6247343 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118924903-A | Application of PI3K/Akt signal pathway agonist in preparation of medicine for treating blood deficiency | 清华德人西安幸福制药有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-118903430-A | Application of PI3K/Akt in preparing medicament for preventing, relieving or treating blood deficiency | 清华德人西安幸福制药有限公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118903173-A | Pharmaceutical composition, pharmaceutical preparation and application | 清华德人西安幸福制药有限公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118903109-A | Application of active ingredient in preparation of Akt signal pathway agonist | 清华德人西安幸福制药有限公司 | 2024-11-08 | — | — | CN | disclosed |
| CN-118903263-A | Application of shengxuebao preparation in preparing medicament for relieving or inhibiting kidney inflammatory reaction | 清华德人西安幸福制药有限公司 | 2024-11-08 | — | — | CN | disclosed |